Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.

Objective: The aim of our study was to explore the immunomodulatory activity of soluble immunoglobulin (Ig)-like transcript (ILT) 3-Fc in pancreatic islet transplantation and to determine its mechanism of action.Research Design and Methods: NOD/SCID mice in which diabetes was induced by streptozotoc...

Descripción completa

Detalles Bibliográficos
Publicado en:Diabetes Vol. 57; no. 7; pp. 1878 - 1887
Autores principales: Vlad G, D'Agati VD, Zhang QY, Liu Z, Ho EK, Mohanakumar T, Hardy MA, Cortesini R, Suciu-Foca N, Vlad, George, D'Agati, Vivette D, Zhang, Qing-Yin, Liu, Zhuoru, Ho, Eric K, Mohanakumar, Thalachallour, Hardy, Mark A, Cortesini, Raffaello, Suciu-Foca, Nicole
Formato: research Journal Article
Publicado: American Diabetes Association Jul2008
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105786424&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105786424
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00121797
        1G6
      jtl: Diabetes
      issn: 00121797
      maglogo: N
    pubinfo:
      dt: Jul2008
      vid: 57
      iid: 7
      pid: 1367
      pub: American Diabetes Association
      place: Arlington, Virginia
    artinfo:
      ui:
        105786424
        105786424
        NLM18420485
        2009983211
        10.2337/db08-0054
        NLM18420485
        105786424
      ppf: 1878
      ppct: 9
      formats:
      tig:
        atl: Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.
      aug:
        au:
          Vlad G
          D'Agati VD
          Zhang QY
          Liu Z
          Ho EK
          Mohanakumar T
          Hardy MA
          Cortesini R
          Suciu-Foca N
          Vlad, George
          D'Agati, Vivette D
          Zhang, Qing-Yin
          Liu, Zhuoru
          Ho, Eric K
          Mohanakumar, Thalachallour
          Hardy, Mark A
          Cortesini, Raffaello
          Suciu-Foca, Nicole
        affil: Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York, USA
      sug:
        subj:
          Diabetes Mellitus Surgery
          Islets of Langerhans Transplantation
          Receptors, Cell Surface Immunology
          T Lymphocytes Immunology
          Xenografts
          Allografts
          Animals
          Diabetes Mellitus Immunology
          Female
          Glycoproteins
          Graft Rejection
          Immunoglobulin Fragments Immunology
          Immunoglobulin Fragments Therapeutic Use
          Immunoglobulin Fragments
          Immunoglobulins Immunology
          Mice
          Polymerase Chain Reaction
          Receptors, Cell Surface Therapeutic Use
          Receptors, Cell Surface
          RNA
          Female
      ab: Objective: The aim of our study was to explore the immunomodulatory activity of soluble immunoglobulin (Ig)-like transcript (ILT) 3-Fc in pancreatic islet transplantation and to determine its mechanism of action.Research Design and Methods: NOD/SCID mice in which diabetes was induced by streptozotocin injection were transplanted with human pancreatic islet cells. Mice in which the transplant restored euglycemia were humanized with allogeneic peripheral blood mononuclear cells and treated with ILT3-Fc or control human IgG or left untreated. The blood glucose level was monitored twice a week, and rejection was diagnosed after two consecutive readings >350 mg/dl. Tolerated and rejected grafts were studied histologically and by immunostaining for human T-cells and insulin production. CD4 and CD8 T-cells from the spleen were studied for suppressor activity, expression of cytokines, and CD40L.Results: Although human T-cell engraftment was similar in all groups, ILT3-Fc-treated mice tolerated the islets for the entire period of observation (91 days), whereas control mice rejected the graft within 7 weeks (P < 0.0001). ILT3-Fc treatment suppressed the expression of cytokines and CD40L and induced the differentiation of human CD8(+) T suppressor cells that inhibited Th alloreactivity against graft HLA antigens. T-cells allostimulated in vitro in the presence of ILT3-Fc inhibited CD40L-induced upregulation of CD40 in human pancreatic islet cells. Histochemical studies showed dramatic differences between human pancreatic islets from tolerant, ILT3-Fc-treated mice and control recipients rejecting the grafts.Conclusions: The data indicated that ILT3-Fc is a potent immunoregulatory agent that suppressed islet allograft rejection in humanized NOD/SCID mice.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N